- Home
- Applications
- asia middle east
- anti inflammatory
Show results for
Refine by
Anti Inflammatory Product Applications Available In In Asia Middle East
8 applications found
Anti-inflammatory, angiogenic and wound healing properties of MSCs are key to successfully treat patients with ...
ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA
Stempeucel® shown anti-inflammatory, immunomodulatory and chondrogenic properties at key stages of ...
ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA
Health Benefits: These compounds have demonstrated anti-inflammatory, antioxidant, and immune-boosting properties, making them valuable in dietary supplements and functional ...
ByEVES ENERGY based in Central Region, SINGAPORE
Introducing Boostbac: BoostBac™ is a dual-strain Bacillus subtilis and Bacillus coagulans probiotic synergistically formulated and clinically proven to reduce persistent systemic inflammation throughout the body. Studies have shown that the anti-inflammatory nature of BoostBac™ positively affects the gut microbiome and can lead to other health benefits, such as reduction of sleep problems. ...
ByMicrobial Discovery Group (MDG) based in Oak Creek, WISCONSIN (USA)
Effecting an estimated one million Americans, Crohn's disease can be highly debilitating and remains a serious burden for both patients and healthcare systems. ...
ByRedHill Biopharma Ltd. based in Tel-Aviv, ISRAEL
Our First DCGI Approved Stem Cell Product: Stempeucel® is the FIRST innovative stem cell based biological product to be approved by DCGI (Indian FDA) for manufacturing and marketing for the treatment of Critical Limb Ischemia (CLI). Stempeucel® product has been licensed to Cipla in India. Stempeutics is seeking partnership for further clinical development and commercialization of Stempeucel® for Global ...
ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA
Seres’ microbiome therapeutics represent a transformative new approach to ...
BySeres Therapeutics, Inc. based in Cambridge, MASSACHUSETTS (USA)
Phase 3 study assessing the Efficacy and Safety of Stempeucel® in Patients with Moderate to Severe ARDS due to COVID ...
ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA